Obs/Obs: Fludrocortisone in Septic Shock and Osmotic Demyelination Syndrome

Retrospective observational studies provide critical, albeit limited, insights into clinical practices where randomized trials are impractical. The analysis of septic shock management suggests that adding fludrocortisone to hydrocortisone may offer a mortality benefit, though these findings remain susceptible to indication bias and residual confounding. Similarly, data on hyponatremia correction reveal that osmotic demyelination syndrome occurs with extreme rarity, contradicting the trend toward increasingly restrictive sodium correction protocols. These studies underscore the necessity of viewing observational data as hypothesis-generating rather than definitive evidence for altering standard care. While clinicians often fear rapid sodium correction, the low incidence of neurological complications suggests that current, highly conservative correction targets may unnecessarily prolong hospital stays and increase resource utilization without providing clear patient safety advantages.